1. Home
  2. LOAN vs RFL Comparison

LOAN vs RFL Comparison

Compare LOAN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

N/A

Current Price

$4.44

Market Cap

51.9M

Sector

Real Estate

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

N/A

Current Price

$1.48

Market Cap

61.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LOAN
RFL
Founded
1989
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Real Estate
Sector
Real Estate
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
51.9M
61.1M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
LOAN
RFL
Price
$4.44
$1.48
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.3K
91.0K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
9.96%
N/A
EPS Growth
2.08
28.28
EPS
0.35
N/A
Revenue
$9,688,641.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.47
N/A
P/E Ratio
$12.69
N/A
Revenue Growth
N/A
43.96
52 Week Low
$4.24
$1.12
52 Week High
$6.05
$3.19

Technical Indicators

Market Signals
Indicator
LOAN
RFL
Relative Strength Index (RSI) 49.56 65.63
Support Level $4.29 $1.41
Resistance Level $4.59 $1.63
Average True Range (ATR) 0.08 0.10
MACD 0.01 0.02
Stochastic Oscillator 76.45 71.25

Price Performance

Historical Comparison
LOAN
RFL

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: